COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 15:06, il y a 10 mois 15 jours Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI) Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI). Nouvelle approche novatrice ciblant les causes sous-jacentes de la TPI Traitement Wayrilz Thrombocytopénie Immunitaire BTK Inhibiteur
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 15:06, il y a 10 mois 15 jours Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Sanofi's Wayrilz, a novel BTK inhibitor, approved in the EU for treating immune thrombocytopenia. Offers multi-immune modulation for ITP management Sanofi BTK Inhibitor Wayrilz Immune Thrombocytopenia Multi-immune Modulation
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 15:05, il y a 10 mois 15 jours Precisely Achieves ISO/IEC 27701 Certification, Strengthening Its Global Privacy Framework Precisely achieves ISO/IEC 27701 certification, enhancing global privacy framework with rigorous privacy standards and accountability for personal data processing Compliance Privacy Data Integrity Precisely ISO/IEC 27701 Certification
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:53, il y a 10 mois 15 jours Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces New CEO Investment Nextech3D.ai confirms successful completion of due diligence for Krafty Labs acquisition, CEO to invest $321,917 through convertible note, reinforcing commitment to shareholders Nextech3D.ai CEO Investment Krafty Labs Acquisition AI-first Event Technology Insider Investment
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:36, il y a 10 mois 16 jours DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies DiNAQOR and academic partners introduce groundbreaking percutaneous platform for organ-specific delivery of advanced therapies, addressing critical challenges in gene and cell therapy development Advanced Therapies DiNAQOR Academic Partners Percutaneous Platform Organ-specific Delivery
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:34, il y a 10 mois 16 jours Targeted adjustment of economic bond terms achieved paragon GmbH & Co. KGaA achieves targeted adjustment of economic bond terms approved by bondholders, including extension of term and waiver of PIK interest element Bondholders Paragon GmbH & Co. KGaA Extension PIK Interest Economic Terms
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:30, il y a 10 mois 16 jours Ørsted brings in Cathay as investor in Greater Changhua 2 Offshore Wind Farm in Taiwan Ørsted partners with Cathay Life Insurance for Greater Changhua 2 Offshore Wind Farm in Taiwan. Joint venture strengthens capital structure and supports renewable energy transition in Taiwan Renewable Energy Ørsted Offshore Wind Farm Taïwan Cathay Life Insurance
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:13, il y a 10 mois 16 jours Hanseatic Global Terminals to invest in greenfield container terminal project in Brazil Hanseatic Global Terminals to invest in greenfield container terminal project in Brazil with Imetame Group. New modern transshipment hub and gateway port planned for Aracruz by 2028 Investment Brazil Container Terminal Hanseatic Global Terminals Imetame Group
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:02, il y a 10 mois 16 jours FDA approves another interchangeable Ranibizumab Biosimilar, Nufymco® – Strengthening US Presence with Zydus as Commercialization Partner FDA approves Formycon's Nufymco® as interchangeable Ranibizumab Biosimilar, partnering with Zydus for commercialization in the US, expanding access to retinal therapies FDA Approval Formycon Zydus Interchangeable Biosimilar Nufymco®
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 13:35, il y a 10 mois 16 jours DeFi Technologies and Valour Mark Strategic Entry into Brazil With Bell-Ringing Ceremony at B3 Exchange DeFi Technologies and Valour celebrate strategic entry into Brazil with bell-ringing ceremony at B3 Exchange, offering BRL-denominated ETPs and BDRs to local investors Brazil DeFi Technologies Valour ETPs B3 Exchange
Publié le 06/11/2026 à 19:06, il y a 1 jour 19 heures ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Publié le 06/11/2026 à 19:04, il y a 1 jour 19 heures ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 06/11/2026 à 19:01, il y a 1 jour 19 heures ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Publié le 06/11/2026 à 19:00, il y a 1 jour 19 heures ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 06/11/2026 à 22:15, il y a 1 jour 16 heures Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Publié le 06/11/2026 à 13:00, il y a 2 jours 1 heure Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Publié le 06/11/2026 à 12:30, il y a 2 jours 2 heures Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Publié le 06/11/2026 à 12:30, il y a 2 jours 2 heures Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Publié le 08/11/2026 à 12:10, il y a 2 heures 28 minutes GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Publié le 08/11/2026 à 10:15, il y a 4 heures 23 minutes 2026 China International Intelligent Communication Forum Held in Wuxi
Publié le 07/11/2026 à 13:35, il y a 1 jour 1 heure Eurobattery Minerals board member and CEO remanded in custody in Sweden
Publié le 06/11/2026 à 20:15, il y a 1 jour 18 heures African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Publié le 06/11/2026 à 20:15, il y a 1 jour 18 heures L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication